These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34854413)

  • 1. COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy.
    Bhardwaj A; Roy V
    Indian J Pharmacol; 2021; 53(5):415-416. PubMed ID: 34854413
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
    Kaur K; Gurnani B
    Indian J Pharmacol; 2021; 53(5):417-419. PubMed ID: 34854414
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of the second wave of COVID-19 in India.
    Asrani P; Eapen MS; Hassan MI; Sohal SS
    Lancet Respir Med; 2021 Sep; 9(9):e93-e94. PubMed ID: 34216547
    [No Abstract]   [Full Text] [Related]  

  • 4. Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
    Singh A; Ahmad N; Varadarajan A; Vikram N; Singh TP; Sharma S; Sharma P
    Int J Biol Macromol; 2021 Sep; 187():988-998. PubMed ID: 34324905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on mucormycosis pathogenesis.
    Ibrahim AS; Kontoyiannis DP
    Curr Opin Infect Dis; 2013 Dec; 26(6):508-15. PubMed ID: 24126718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis.
    Arora N; Gudipati A; Kundu R; Prabhakar N; Suri V; Malhotra P; Jain A
    Lancet Infect Dis; 2021 Nov; 21(11):1611. PubMed ID: 34717815
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolving the equation between mucormycosis and COVID-19 disease.
    Pasrija R; Naime M
    Mol Biol Rep; 2022 Apr; 49(4):3349-3356. PubMed ID: 35064406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.
    Ibrahim AS
    Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Iron Chelators in Mucormycosis.
    Mahalmani V; Sarma P; Prakash A; Medhi B
    Indian J Pharmacol; 2021; 53(4):261-263. PubMed ID: 34414902
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors.
    Hassan MIA; Voigt K
    Med Mycol; 2019 Apr; 57(Supplement_2):S245-S256. PubMed ID: 30816980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Advancements in the understanding of Mucorales biology and the management of mucormycosis.
    Chamilos G; Garre V
    Front Cell Infect Microbiol; 2024; 14():1427252. PubMed ID: 38836052
    [No Abstract]   [Full Text] [Related]  

  • 13. How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
    Lugito NPH; Cucunawangsih C
    Mycopathologia; 2021 Dec; 186(6):877-882. PubMed ID: 34623597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in rhinocerebral mucormycosis: is iron the key?
    Bhargava P
    Neurol India; 2007; 55(4):416. PubMed ID: 18040125
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The iron chelator deferasirox protects mice from mucormycosis through iron starvation.
    Ibrahim AS; Gebermariam T; Fu Y; Lin L; Husseiny MI; French SW; Schwartz J; Skory CD; Edwards JE; Spellberg BJ
    J Clin Invest; 2007 Sep; 117(9):2649-57. PubMed ID: 17786247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis.
    Walsh TJ; Bloom BE; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S1-4. PubMed ID: 22247440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Pathogenesis of Mucormycoses.
    Petrikkos G; Tsioutis C
    Clin Ther; 2018 Jun; 40(6):894-902. PubMed ID: 29631910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Peripheral Smear Chat.
    Alabbadi AM; Yassin DF; Mansour AT; Al-Abbadi MA
    Acta Cytol; 2021; 65(1):1-3. PubMed ID: 32799199
    [No Abstract]   [Full Text] [Related]  

  • 20. Genes, Pathways, and Mechanisms Involved in the Virulence of Mucorales.
    Lax C; Pérez-Arques C; Navarro-Mendoza MI; Cánovas-Márquez JT; Tahiri G; Pérez-Ruiz JA; Osorio-Concepción M; Murcia-Flores L; Navarro E; Garre V; Nicolás FE
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32188171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.